[go: up one dir, main page]

AR051236A1 - Metabolitos glucuronidos de tigeciclina y epimeros de los mismos - Google Patents

Metabolitos glucuronidos de tigeciclina y epimeros de los mismos

Info

Publication number
AR051236A1
AR051236A1 ARP050104639A ARP050104639A AR051236A1 AR 051236 A1 AR051236 A1 AR 051236A1 AR P050104639 A ARP050104639 A AR P050104639A AR P050104639 A ARP050104639 A AR P050104639A AR 051236 A1 AR051236 A1 AR 051236A1
Authority
AR
Argentina
Prior art keywords
tigecycline
tigecicline
glucuronid
metabolites
same
Prior art date
Application number
ARP050104639A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR051236A1 publication Critical patent/AR051236A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Reivindicacion 1: Un metabolito glucuronido de tigeciclina preparado mediante el tratamiento de seres humanos con tigeciclina. Reivindicacion 7: Un proceso para preparar un metabolito glucuronido de tigeciclina que comprende los pasos de: a) proveer una dosis de tigeciclina a un ser humano; b) obtener una muestra de suero, orina o heces de dicho ser humano; y c) extraer dicha muestra para obtener un metabolito glucuronido de tigeciclina. Reivindicacion 11: Un compuesto seleccionado de las formulas (1) a (4).
ARP050104639A 2004-11-05 2005-11-04 Metabolitos glucuronidos de tigeciclina y epimeros de los mismos AR051236A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62512104P 2004-11-05 2004-11-05

Publications (1)

Publication Number Publication Date
AR051236A1 true AR051236A1 (es) 2006-12-27

Family

ID=36337018

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104639A AR051236A1 (es) 2004-11-05 2005-11-04 Metabolitos glucuronidos de tigeciclina y epimeros de los mismos

Country Status (22)

Country Link
US (1) US7534766B2 (es)
EP (1) EP1807441A2 (es)
JP (1) JP2008519038A (es)
KR (1) KR20070085761A (es)
CN (1) CN101132799A (es)
AR (1) AR051236A1 (es)
AU (1) AU2005304957A1 (es)
BR (1) BRPI0517715A (es)
CA (1) CA2586245A1 (es)
CR (1) CR9111A (es)
GT (1) GT200500320A (es)
HN (1) HN2005030775A (es)
IL (1) IL182640A0 (es)
MX (1) MX2007005105A (es)
NO (1) NO20072226L (es)
PA (1) PA8652001A1 (es)
PE (1) PE20061048A1 (es)
RU (1) RU2007116800A (es)
SV (1) SV2006002294A (es)
TW (1) TW200628485A (es)
WO (1) WO2006052717A2 (es)
ZA (1) ZA200703624B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2695259C (en) * 2007-07-31 2016-05-24 Gilead Colorado, Inc. Metabolites and derivatives of ambrisentan
US8766177B2 (en) 2010-10-11 2014-07-01 University Of North Texas Nanomanipulation coupled nanospray mass spectrometry (NMS)
JP6134191B2 (ja) 2013-04-07 2017-05-24 村川 惠美 回転型セミバッチald装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494903A (en) * 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
EP0536515B1 (en) 1991-10-04 2001-12-19 American Cyanamid Company Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5420272A (en) 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
US5328902A (en) 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US20050137174A1 (en) 2003-07-09 2005-06-23 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050143352A1 (en) 2003-07-09 2005-06-30 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20050148553A1 (en) * 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Also Published As

Publication number Publication date
US20060128950A1 (en) 2006-06-15
TW200628485A (en) 2006-08-16
KR20070085761A (ko) 2007-08-27
HN2005030775A (es) 2006-12-18
ZA200703624B (en) 2009-10-28
RU2007116800A (ru) 2008-12-10
CN101132799A (zh) 2008-02-27
EP1807441A2 (en) 2007-07-18
SV2006002294A (es) 2006-10-13
BRPI0517715A (pt) 2008-10-21
US7534766B2 (en) 2009-05-19
JP2008519038A (ja) 2008-06-05
GT200500320A (es) 2006-06-02
CA2586245A1 (en) 2006-05-18
WO2006052717A2 (en) 2006-05-18
MX2007005105A (es) 2007-06-26
AU2005304957A1 (en) 2006-05-18
NO20072226L (no) 2007-06-04
WO2006052717A3 (en) 2007-11-15
PE20061048A1 (es) 2006-11-15
PA8652001A1 (es) 2006-10-13
CR9111A (es) 2008-01-21
IL182640A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
AR051800A1 (es) Anticuerpos a beta usados en mejorar la cognicion
AR062841A1 (es) Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO20085004L (no) Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler
CR8402A (es) Indazol-o-glucosidos sustitutos
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
ECSP099529A (es) Inhibidores de cinasa mapk/erk
AR052238A1 (es) Formulacion de tabletas estables
BRPI0416881A (pt) método para reduzir odor excrementos de um animal doméstico.
NO20032734L (no) Nye 1,2-difenylazetidinoner, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og anvendelse av disse forbehandling av sykdommer fra lipidstoffskiftet
UY28572A1 (es) Compuestos novedosos
CR10967A (es) Formas polimorficas de 3-(4-amino-1-oxo-1,3 dihidro-isoindol-2-il) piperidina-2,6-diona (divisional exp. 8291)
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
UY30736A1 (es) Compuestos quimicos 537
GT200500359A (es) Compuestos organicos
AR109263A2 (es) Composición que comprende moxidectina
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
CO5601045A2 (es) Procedimiento para la fabricacion de compuestos organicos
NO20072290L (no) Organiske forbindelser.
UY30187A1 (es) Nuevas modificaciones cristalinas y solvato
UY26656A1 (es) "metabolitos agonistas/antagonistas de estrogeno"
UY28870A1 (es) Derivados heterocíclicos, composiciones y proceso de preparación
AR037756A1 (es) Anticuerpo que inhibe la actividad del factor de las celulas precursoras y su uso para el tratamiento del asma.
UY28148A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion

Legal Events

Date Code Title Description
FB Suspension of granting procedure